Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
The Pharma Data
NOVEMBER 9, 2020
Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for NVX-CoV2373, the Company’s COVID-19 vaccine candidate. GAITHERSBURG, Md., Glenn, M.D., and globally.”.
Let's personalize your content